Adverse drug reactions · Adult patients with cancer who develop a low‐risk febrile neutropaenic event
Outpatients showed no clear difference in adverse drugs reactions compared with inpatients ‐ adults (low certainty).
1 finding from 1 review
Duration of neutropaenia (days) · Adult patients with cancer who develop a low‐risk febrile neutropaenic event
1 finding from 1 review
Length of hospitalisation (days) · Adult patients with cancer who develop a low‐risk febrile neutropaenic event
1 finding from 1 review
Treatment failure · Children with cancer who develop a low‐risk febrile neutropaenic event
Outpatients showed no clear difference in treatment failure compared with inpatients ‐ children (moderate certainty).
1 finding from 1 review
All‐cause mortality · Children with cancer who develop a low‐risk febrile neutropaenic event
Outpatients showed no clear difference in mortality compared with inpatients ‐ children (moderate certainty).
1 finding from 1 review
Fever clearance time · Children with cancer who develop a low‐risk febrile neutropaenic event
1 finding from 1 review
Urological symptom scores · men with lower urinary tract symptoms secondary to benign prostatic obstruction
1 finding from 1 review
Bother (HRQoLc at 12 months) · men with lower urinary tract symptoms secondary to benign prostatic obstruction
1 finding from 1 review
TUR syndrome · men with lower urinary tract symptoms secondary to benign prostatic obstruction
BTURP probably leads to lower TUR syndrome compared with MTURP (moderate certainty).
1 finding from 1 review
Urinary incontinence late postnatal period (> 6‐12 months) · men with lower urinary tract symptoms secondary to benign prostatic obstruction
BTURP showed no clear difference in urinary incontinence at 12 months compared with MTURP (low certainty).
1 finding from 1 review
Blood transfusion · men with lower urinary tract symptoms secondary to benign prostatic obstruction
BTURP probably leads to lower blood transfusion compared with MTURP (moderate certainty).
1 finding from 1 review
Re‐TURP · men with lower urinary tract symptoms secondary to benign prostatic obstruction
BTURP showed no clear difference in re‐TURP compared with MTURP (low certainty).
1 finding from 1 review
Erectile function · men with lower urinary tract symptoms secondary to benign prostatic obstruction
1 finding from 1 review
Disease activity · people with rheumatoid arthritis with low disease activity using a standard dose of anti‐TNF agents
1 finding from 1 review
Proportion participants that switched to another biologic due to loss of response ‐ not measured · people with rheumatoid arthritis with low disease activity using a standard dose of anti‐TNF agents
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Proportion of participants with minimal radiographic progression · people with rheumatoid arthritis with low disease activity using a standard dose of anti‐TNF agents
Anti‐TNF discontinuation leads to higher proportion participants with minimal radiographic progression compared with anti‐TNF continuation (high certainty).
1 finding from 1 review
Function · people with rheumatoid arthritis with low disease activity using a standard dose of anti‐TNF agents
1 finding from 1 review
Number of serious adverse events · people with rheumatoid arthritis with low disease activity using a standard dose of anti‐TNF agents
It is very uncertain whether anti‐TNF discontinuation changes number of serious adverse events compared with anti‐TNF continuation (very low certainty).
1 finding from 1 review
Withdrawals due to adverse events · people with rheumatoid arthritis with low disease activity using a standard dose of anti‐TNF agents
Anti‐TNF discontinuation showed no clear difference in withdrawals due to adverse events compared with anti‐TNF continuation (moderate certainty).
1 finding from 1 review
Disease activity · people with rheumatoid arthritis with low disease activity using a standard dose of anti‐TNF agents
1 finding from 1 review